Ligands of Immunopharmacology

Lipopolysaccharides (LPS) is an endotoxin derived from the outer leaflet of the outer membrane of Gram-negative bacteria. Lipopolysaccharides consists of an antigen O-specific chain, a core oligosaccharide and lipid A. Lipopolysaccharides is a

Luteolin 5-O-glucoside, a major flavonoidfrom Cirsium maackii , possesses anti-inflammatory activity. Luteolin 5-O-glucoside inhibits LPS-induced NO production and t-BHP-induced ROS generation. Luteolin 5-O-glucoside suppresses the expression of

Luteolin 5-O-glucoside, a major flavonoidfrom Cirsium maackii , possesses anti-inflammatory activity. Luteolin 5-O-glucoside inhibits LPS-induced NO production and t-BHP-induced ROS generation. Luteolin 5-O-glucoside suppresses the expression of

Luteolin 5-O-glucoside, a major flavonoidfrom Cirsium maackii , possesses anti-inflammatory activity. Luteolin 5-O-glucoside inhibits LPS-induced NO production and t-BHP-induced ROS generation. Luteolin 5-O-glucoside suppresses the expression of

MAX-10181 (PD-1/PD-L1-IN-30) is a PD-1/PD-L1 binding inhibitor, with an IC 50 value of 0.018 μM. MAX-10181 can be used for research of cancers and other related diseases.In VitroMAX-10181 (Example 68) inhibits PD-1/PD-L1 binding with an IC 50 value

MAX-10181 (PD-1/PD-L1-IN-30) is a PD-1/PD-L1 binding inhibitor, with an IC 50 value of 0.018 μM. MAX-10181 can be used for research of cancers and other related diseases.In VitroMAX-10181 (Example 68) inhibits PD-1/PD-L1 binding with an IC 50 value

MAX-10181 (PD-1/PD-L1-IN-30) is a PD-1/PD-L1 binding inhibitor, with an IC 50 value of 0.018 μM. MAX-10181 can be used for research of cancers and other related diseases.In VitroMAX-10181 (Example 68) inhibits PD-1/PD-L1 binding with an IC 50 value

MIF098 is a macrophage migration inhibitory factor ( MIF ) antagonist. MIF098 inhibits proliferation, migration and fibrosis of pulmonary smooth muscle cells. MIF098 can be used for immunoinflammation-related disease research.In VitroMIF098 (0-10

MIF098 is a macrophage migration inhibitory factor ( MIF ) antagonist. MIF098 inhibits proliferation, migration and fibrosis of pulmonary smooth muscle cells. MIF098 can be used for immunoinflammation-related disease research.In VitroMIF098 (0-10

MIF098 is a macrophage migration inhibitory factor ( MIF ) antagonist. MIF098 inhibits proliferation, migration and fibrosis of pulmonary smooth muscle cells. MIF098 can be used for immunoinflammation-related disease research.In VitroMIF098 (0-10

Mifamurtide sodium (MTP-PE sodium), an analog of the muramyl dipeptide (MDP), is a nonspecific immunomodulator by stimulating the immune response activating macrophages and monocytes. Mifamurtide sodium, an orphan agent, is a specific ligand of NOD2

Mifamurtide TFA (MTP-PE TFA), an analog of the muramyl dipeptide (MDP), is a nonspecific immunomodulator by stimulating the immune response activating macrophages and monocytes. Mifamurtide TFA, an orphan agent, is a specific ligand of NOD2 used as